Jasper Therapeutics, Inc. (JSPRW) SEC Filings — 2025
14 SEC filings for Jasper Therapeutics, Inc. (JSPRW) in 2025.
Filings
- Jasper Therapeutics, Inc. 8-K Filing — 8-K · Dec 2, 2025
- Jasper Therapeutics' Losses Mount, Cash Dwindles Amid R&D Surge — 10-Q · Nov 10, 2025
- Jasper Therapeutics Enters Material Definitive Agreement — 8-K · Sep 19, 2025
- Jasper Therapeutics' Losses Mount, Cash Dwindles Amid R&D Surge — 10-Q · Aug 13, 2025
- Jasper Therapeutics Reports Key Corporate Events — 8-K · Jul 9, 2025
- Jasper Therapeutics Files 8-K — 8-K · Jul 7, 2025
- Jasper Therapeutics Files 8-K on Security Holder Vote Matters — 8-K · Jul 3, 2025
- Jasper Therapeutics Files 8-K — 8-K · Jun 16, 2025
- Jasper Therapeutics Files Definitive Proxy Statement — DEF 14A · May 19, 2025
- Jasper Therapeutics Files Q1 2025 10-Q — 10-Q · May 12, 2025
- Jasper Therapeutics Terminates Material Agreement — 8-K · Mar 19, 2025
- Jasper Therapeutics Files 2024 Annual Report — 10-K · Feb 28, 2025
- Jasper Therapeutics Files 8-K on Financials — 8-K · Feb 27, 2025
- Jasper Therapeutics Files 8-K — 8-K · Jan 8, 2025